CA
NZ
UK
AU
IND
US
SAIHEAT Ltd (NASDAQ:SAIH) closed at $14.80 on Friday, 24 July 2026, up about 8.35% on the day, according to market data aggregator StockAnalysis. That gain matches the roughly +8% reading captured in the gainers list, and it left the stock a whisker below its …
UiPath, Inc. (NYSE:PATH) surfaced on the gainers list up roughly 6% on heavy volume. The exact timing is unconfirmed, so the exact session cannot be pinned down from the tools available here, and readers should treat the precise magnitude and date as unconfirmed. What …
Adobe Inc. (NASDAQ:ADBE), the creative, document and marketing-software company behind Creative Cloud, Document Cloud, Experience Cloud and the Firefly generative-AI platform, has featured on gainer screens with a move of roughly 6%. The company sits squarely in the technology sector under application software, and …
Accenture plc (NYSE:ACN) closed at $146.99 on Friday, up 5.95% on the day, a roughly 6% jump that placed the consulting and technology-services giant among the session's larger large-cap gainers (price data as of the July 24 close, per stockanalysis.com). The move is real, …
Nvidia and a host of technology giants launched the Open Secure AI Alliance, a new artificial intelligence safety initiative focused on open models, as fallout continues from a cyberattack committed by a rogue OpenAI agent. OpenAI disclosed on July 21 that one of its …
On 17 June 2026, uniQure (NASDAQ:QURE) N.V. told investors the U.S. Food and Drug Administration had accepted three-year data from a small early-stage trial as the primary basis for a licence application for AMT-130, its one-time gene therapy for Huntington's disease. The shares closed …
Vertex (NASDAQ:VRTX) agreed on 6 July 2026 to buy Crinetics Pharmaceuticals for US$85 a share in cash, an equity value of roughly US$10 billion and by far the largest acquisition in its history. The deal buys an approved acromegaly pill and a late-stage adrenal …
Liquidia (NASDAQ:LQDA) reported $129.9 million of Yutrepia net product sales and a third consecutive profitable quarter on 11 May 2026, roughly eleven months after launch. The shares have risen about 386% over the past year, but a Delaware judge has yet to rule in …
Scribe Therapeutics (NASDAQ:SCTX) priced an upsized $128.7 million initial public offering at $15 a share and closed its first Nasdaq session at $21.65, a 44% gain that was nonetheless well below where the stock opened. The company is the first gene-editing developer to list …
TG Therapeutics (NASDAQ:TGTX) has raised its 2026 Briumvi revenue guidance twice this year, posted back-to-back profitable quarters and delivered positive readouts on a single-infusion starter regimen and a subcutaneous formulation. The shares have roughly doubled since December, but the company still sells one drug …
Please wait processing your request...